Back to Search Start Over

A Distinct Gene Module for Dysfunction Uncoupled from Activation in Tumor-Infiltrating T Cells

Authors :
Massachusetts Institute of Technology. Computational and Systems Biology Program
Massachusetts Institute of Technology. Department of Biology
Ludwig Center for Molecular Oncology (Massachusetts Institute of Technology)
Koch Institute for Integrative Cancer Research at MIT
Marjanovic, Nemanja
Regev, Aviv
Singer, Meromit
Cong, Le
Kowalczyk, Monika S.
Zhang, Huiyuan
Nyman, Jackson
Sakuishi, Kaori
Kurtulus, Sema
Gennert, David
Xia, Junrong
Kwon, John Y.H.
Nevin, James
Herbst, Rebecca H.
Yanai, Itai
Rozenblatt-Rosen, Orit
Kuchroo, Vijay K.
Anderson, Ana C.
Wang, Chao
Massachusetts Institute of Technology. Computational and Systems Biology Program
Massachusetts Institute of Technology. Department of Biology
Ludwig Center for Molecular Oncology (Massachusetts Institute of Technology)
Koch Institute for Integrative Cancer Research at MIT
Marjanovic, Nemanja
Regev, Aviv
Singer, Meromit
Cong, Le
Kowalczyk, Monika S.
Zhang, Huiyuan
Nyman, Jackson
Sakuishi, Kaori
Kurtulus, Sema
Gennert, David
Xia, Junrong
Kwon, John Y.H.
Nevin, James
Herbst, Rebecca H.
Yanai, Itai
Rozenblatt-Rosen, Orit
Kuchroo, Vijay K.
Anderson, Ana C.
Wang, Chao
Publication Year :
2018

Abstract

Reversing the dysfunctional T cell state that arises in cancer and chronic viral infections is the focus of therapeutic interventions; however, current therapies are effective in only some patients and some tumor types. To gain a deeper molecular understanding of the dysfunctional T cell state, we analyzed population and single-cell RNA profiles of CD8+tumor-infiltrating lymphocytes (TILs) and used genetic perturbations to identify a distinct gene module for T cell dysfunction that can be uncoupled from T cell activation. This distinct dysfunction module is downstream of intracellular metallothioneins that regulate zinc metabolism and can be identified at single-cell resolution. We further identify Gata-3, a zinc-finger transcription factor in the dysfunctional module, as a regulator of dysfunction, and we use CRISPR-Cas9 genome editing to show that it drives a dysfunctional phenotype in CD8+TILs. Our results open novel avenues for targeting dysfunctional T cell states while leaving activation programs intact.

Details

Database :
OAIster
Notes :
application/pdf
Publication Type :
Electronic Resource
Accession number :
edsoai.on1155491263
Document Type :
Electronic Resource